Line 17: |
Line 17: |
| ==WHO Classification Pages (Includes Links to Content)== | | ==WHO Classification Pages (Includes Links to Content)== |
| | | |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] |
| | | |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged|B-ALL with t(v;11q23.3); KMT2A-Rearranged]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement|B-ALL with t(v;11q23.3); KMT2A-Rearranged]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy|B-ALL with Hyperdiploidy]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy|B-ALL with Hyperdiploidy]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy|B-ALL with Hypodiploidy]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy|B-ALL with Hypodiploidy]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like|B-ALL, BCR-ABL1-Like]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features|B-ALL, BCR-ABL1-Like]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with iAMP21|B-ALL with iAMP21]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21|B-ALL with iAMP21]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified|B-ALL, Not Otherwise Specified]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-ALL, Not Otherwise Specified]] |
| | | |
− | *[[T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]] | + | *[[HAEM4:T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]] |
| | | |
− | - [[Early T-Cell Precursor Lymphoblastic Leukemia]] | + | - [[HAEM5:Early T-precursor lymphoblastic leukaemia / lymphoma]] |
− | - [[NK-Lymphoblastic Leukemia/Lymphoma]] | + | - [[HAEM4:NK-Lymphoblastic Leukemia/Lymphoma]] |
| | | |
| ==Other Related Pages (Includes Links to Content)== | | ==Other Related Pages (Includes Links to Content)== |
| | | |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]] |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6]] |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)]] |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions]] |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements]] |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)]] |
− | *[[T-ALL/MEF2C]] | + | *[[HAEM4:T-ALL/MEF2C]] |
− | *[[T-cell lymphoblastic leukemia with t(7;14)(p15;q32)]] | + | *[[HAEM4:T-cell lymphoblastic leukemia with t(7;14)(p15;q32)]] |
| | | |
| ==Additional Information== | | ==Additional Information== |